S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BLO
Cannabix Technologies
C$0.00
C$0.40
C$2.95
N/AN/A301,179 shs188,592 shs
Cannabix Technologies Inc. stock logo
BLOZF
Cannabix Technologies
$0.19
+3.7%
$0.16
$0.12
$0.29
N/A1.8390,996 shs22,225 shs
Cochlear Limited stock logo
CHEOY
Cochlear
$101.96
-0.6%
$108.76
$73.73
$114.50
$13.36B0.913,291 shs4,718 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BLO
Cannabix Technologies
0.00%0.00%0.00%0.00%0.00%
Cannabix Technologies Inc. stock logo
BLOZF
Cannabix Technologies
+7.69%+14.29%+19.58%+10.83%-25.18%
Cochlear Limited stock logo
CHEOY
Cochlear
+1.70%-0.22%-5.98%+7.21%+22.97%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BLO
Cannabix Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Cannabix Technologies Inc. stock logo
BLOZF
Cannabix Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Cochlear Limited stock logo
CHEOY
Cochlear
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BLO
Cannabix Technologies
N/AN/AN/AN/A
Cannabix Technologies Inc. stock logo
BLOZF
Cannabix Technologies
N/AN/AN/AN/A
Cochlear Limited stock logo
CHEOY
Cochlear
1.50
ReduceN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BLO
Cannabix Technologies
N/AN/AN/AN/AN/AN/A
Cannabix Technologies Inc. stock logo
BLOZF
Cannabix Technologies
N/AN/AN/AN/A$0.04 per shareN/A
Cochlear Limited stock logo
CHEOY
Cochlear
$1.32B10.14N/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BLO
Cannabix Technologies
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Cannabix Technologies Inc. stock logo
BLOZF
Cannabix Technologies
-$1.61M-$0.01N/AN/AN/A-39.99%-38.76%N/A
Cochlear Limited stock logo
CHEOY
Cochlear
N/AN/A0.0044.52N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BLO
Cannabix Technologies
N/AN/AN/AN/AN/A
Cannabix Technologies Inc. stock logo
BLOZF
Cannabix Technologies
N/AN/AN/AN/AN/A
Cochlear Limited stock logo
CHEOY
Cochlear
$1.161.14%N/AN/AN/A

Latest BLOZF, BLO, and CHEOY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/16/2024
Cochlear Limited stock logo
CHEOY
Cochlear
$0.03361%3/21/20243/22/20244/30/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BLO
Cannabix Technologies
N/AN/AN/A
Cannabix Technologies Inc. stock logo
BLOZF
Cannabix Technologies
N/A
47.80
47.80
Cochlear Limited stock logo
CHEOY
Cochlear
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
BLO
Cannabix Technologies
N/A
Cannabix Technologies Inc. stock logo
BLOZF
Cannabix Technologies
N/A
Cochlear Limited stock logo
CHEOY
Cochlear
N/A

Insider Ownership

CompanyInsider Ownership
BLO
Cannabix Technologies
N/A
Cannabix Technologies Inc. stock logo
BLOZF
Cannabix Technologies
N/A
Cochlear Limited stock logo
CHEOY
Cochlear
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BLO
Cannabix Technologies
N/AN/AN/ANot Optionable
Cannabix Technologies Inc. stock logo
BLOZF
Cannabix Technologies
N/AN/AN/ANot Optionable
Cochlear Limited stock logo
CHEOY
Cochlear
4,800130.99 millionN/ANot Optionable

BLOZF, BLO, and CHEOY Headlines

SourceHeadline
ACCC waives through Cochlear’s revised rival buyACCC waives through Cochlear’s revised rival buy
innovationaus.com - April 4 at 1:33 AM
Cochlears Oticon Implants Acquisition Approved by Australian RegulatorCochlear's Oticon Implants Acquisition Approved by Australian Regulator
marketwatch.com - April 3 at 8:32 PM
ACCC will not oppose revised Cochlear, Oticon Medical transactionACCC will not oppose revised Cochlear, Oticon Medical transaction
accc.gov.au - April 3 at 8:32 PM
Can a vaccine slow down the Cochlear train?Can a vaccine slow down the Cochlear train?
afr.com - March 27 at 9:19 PM
Cochlear Ltds Dividend AnalysisCochlear Ltd's Dividend Analysis
finance.yahoo.com - March 20 at 7:06 PM
Cochlear Limited (ASX: COH) - Share Price and ResearchCochlear Limited (ASX: COH) - Share Price and Research
intelligentinvestor.com.au - March 16 at 10:23 AM
Cochlear Implant Scheme now renamed ‘Shravana Sanjeevini’Cochlear Implant Scheme now renamed ‘Shravana Sanjeevini’
starofmysore.com - March 12 at 12:04 PM
Cochlear calls for action in Washington D.C. ahead of World Hearing DayCochlear calls for action in Washington D.C. ahead of World Hearing Day
prnewswire.com - February 28 at 4:48 PM
New Tarabichi Mondy Cochlear Implant Center pledges major contributions towards addressing hearing loss and deafness in the UAENew Tarabichi Mondy Cochlear Implant Center pledges major contributions towards addressing hearing loss and deafness in the UAE
zawya.com - February 28 at 9:10 AM
Cochlear Limited - Depositary Receipt () (CHEOY) Price Target Increased by 11.05% to 94.91Cochlear Limited - Depositary Receipt () (CHEOY) Price Target Increased by 11.05% to 94.91
msn.com - February 25 at 12:53 AM
Cochlear announces 2024 winners of annual scholarshipsCochlear announces 2024 winners of annual scholarships
prnewswire.com - February 22 at 10:15 AM
Cochlear price target raised by A$20 at UBS, heres whyCochlear price target raised by A$20 at UBS, here's why
realmoney.thestreet.com - February 19 at 9:07 PM
Cochlear price target raised by A$18 at Morgan Stanley, heres whyCochlear price target raised by A$18 at Morgan Stanley, here's why
realmoney.thestreet.com - February 19 at 9:07 PM
What we learnt from Cochlear, Wesptac, Ampol and Bendigo’s resultsWhat we learnt from Cochlear, Wesptac, Ampol and Bendigo’s results
afr.com - February 19 at 9:47 AM
Cochlear lifts dividend thanks to strong first-half resultsCochlear lifts dividend thanks to strong first-half results
thewest.com.au - February 18 at 11:42 PM
Citi Reaffirms Their Sell Rating on Cochlear Limited (CHEOF)Citi Reaffirms Their Sell Rating on Cochlear Limited (CHEOF)
markets.businessinsider.com - February 18 at 11:42 PM
Cochlears first-half profit up 35pct to $191 millionCochlear's first-half profit up 35pct to $191 million
msn.com - February 18 at 11:42 PM
Cochlear’s profit is booming, but says plenty of room to growCochlear’s profit is booming, but says plenty of room to grow
theaustralian.com.au - February 18 at 11:42 PM
Cochlear share price falls despite 29% dividend boostCochlear share price falls despite 29% dividend boost
fool.com.au - February 18 at 11:42 PM
Cochlear surpasses expectationsCochlear surpasses expectations
sharecafe.com.au - February 18 at 6:41 PM
Cochlear Hoists Dividend on 35% Jump in 1H Profit -- UpdateCochlear Hoists Dividend on 35% Jump in 1H Profit -- Update
marketwatch.com - February 18 at 6:41 PM
Cochlear’s big first half delivers best dividend in a decadeCochlear’s big first half delivers best dividend in a decade
afr.com - February 18 at 6:41 PM
Cochlear Implant Market to Accumulate a Valuation of USD 4.0 Billion by 2030, Advancing at a 10.36% CAGR | MarketDigitsCochlear Implant Market to Accumulate a Valuation of USD 4.0 Billion by 2030, Advancing at a 10.36% CAGR | MarketDigits
finance.yahoo.com - February 16 at 2:30 PM
Morgans downgrades Cochlear Limited (CHEOF) to a HoldMorgans downgrades Cochlear Limited (CHEOF) to a Hold
markets.businessinsider.com - February 12 at 8:39 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Cannabix Technologies

CNSX:BLO
Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for law enforcement and the work place in North America. It develops drug-testing devices that will detect tetrahydrocannabinol using breath samples at roadside and identify drivers under the influence of marijuana. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.
Cannabix Technologies logo

Cannabix Technologies

OTCMKTS:BLOZF
Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for employers, law enforcement, workplaces, and laboratories in the United States. It develops tetrahydrocannabinol breath analyzers, a point of care breath testing tool for the rapid detection of recent cannabis use; MS breath sampler; and contactless alcohol breathalyzer, as well as breath collection units. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.
Cochlear logo

Cochlear

OTCMKTS:CHEOY
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.